Friday, July 18, 2014

Why Does the FDA Only Act (or Overreact) After a Crisis? The 2012 Meningitis Outbreak By John R. Graham Filed under Policy

Updates on July 17, 2014 The FDA has just issued regulations and policy positions on compounding pharmacies that sell their products across state lines. A compounding pharmacy is a pharmacy that practices like most pharmacies did until well into the 20th century: Pharmacists actually compound chemicals into a medicine, rather than dispensing a pill or vial made by a manufacturer. That is why the mortar and pestle is the traditional symbol of pharmacy. Traditionally, the Food and Drug Administration did not scrutinize these pharmacies. In 2012, the New England Compounding Center was responsible for sending impure steroid injections to twenty states, which caused an outbreak of fungal meningitis that infected 751 people and killed 64.
 See more at: http://healthblog.ncpa.org/why-does-the-fda-only-act-or-overreact-after-a-crisis-the-2012-meningitis-outbreak/comment-page-1/#comment-286940

No comments: